Find Murepavadin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 944252-63-5, Murepavadin [inn], Pol7080, Ro7033877, 0d02gry87z, Ro-7033877
Molecular Formula
C73H112N22O16
Molecular Weight
1553.8  g/mol
InChI Key
RIDRXGOBXZLKHZ-NZUANIILSA-N
FDA UNII
0D02GRY87Z

Murepavadin
Murepavadin is under investigation in clinical trial NCT02110459 (Pharmacokinetics and Safety of POL7080 in Patients With Renal Impairment).
1 2D Structure

Murepavadin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(3R,9S,12S,15S,18S,21S,24S,27R,30S,33S,36S,39S,42S,45S)-15,18,24,27,33-pentakis(2-aminoethyl)-30-(3-aminopropyl)-36-[(2S)-butan-2-yl]-42-[(1R)-1-hydroxyethyl]-9-(hydroxymethyl)-21,39-bis(1H-indol-3-ylmethyl)-12-methyl-1,7,10,13,16,19,22,25,28,31,34,37,40,43-tetradecazatricyclo[43.3.0.03,7]octatetracontane-2,8,11,14,17,20,23,26,29,32,35,38,41,44-tetradecone
2.1.2 InChI
InChI=1S/C73H112N22O16/c1-5-38(2)58-70(108)88-52(24-30-79)65(103)83-47(17-10-25-74)62(100)85-49(21-27-76)63(101)86-51(23-29-78)66(104)89-53(33-41-35-80-45-15-8-6-13-43(41)45)67(105)87-50(22-28-77)64(102)84-48(20-26-75)61(99)82-39(3)60(98)91-55(37-96)72(110)95-32-12-19-57(95)73(111)94-31-11-18-56(94)69(107)93-59(40(4)97)71(109)90-54(68(106)92-58)34-42-36-81-46-16-9-7-14-44(42)46/h6-9,13-16,35-36,38-40,47-59,80-81,96-97H,5,10-12,17-34,37,74-79H2,1-4H3,(H,82,99)(H,83,103)(H,84,102)(H,85,100)(H,86,101)(H,87,105)(H,88,108)(H,89,104)(H,90,109)(H,91,98)(H,92,106)(H,93,107)/t38-,39-,40+,47-,48-,49+,50-,51-,52-,53-,54-,55-,56-,57+,58-,59-/m0/s1
2.1.3 InChI Key
RIDRXGOBXZLKHZ-NZUANIILSA-N
2.1.4 Canonical SMILES
CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)N3CCCC3C(=O)NC(C(=O)NC(C(=O)N1)CC4=CNC5=CC=CC=C54)C(C)O)CO)C)CCN)CCN)CC6=CNC7=CC=CC=C76)CCN)CCN)CCCN)CCN
2.1.5 Isomeric SMILES
CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2CCC[C@@H]2C(=O)N3CCC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC4=CNC5=CC=CC=C54)[C@@H](C)O)CO)C)CCN)CCN)CC6=CNC7=CC=CC=C76)CCN)CCN)CCCN)CCN
2.2 Other Identifiers
2.2.1 UNII
0D02GRY87Z
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Cyclo(-l-threonyl-l-tryptophanyl-l-isoleucyl-l-2,4-diaminobutyryl-l-ornithyl-d-2,4-diaminobutyryl-l-2,4-diaminobutyryl-l-tryptophanyl-l-2,4-diaminobutyryl-l-2,4-diaminobutyryl-l-alanyl-l-seryl-d-prolyl-l-prolyl), Acetate Salt

2. Pol7080

2.3.2 Depositor-Supplied Synonyms

1. 944252-63-5

2. Murepavadin [inn]

3. Pol7080

4. Ro7033877

5. 0d02gry87z

6. Ro-7033877

7. Pol-7080

8. Cyclo(l-alanyl-l-seryl-d-prolyl-l-prolyl-l-threonyl-l-tryptophyl-l-isoleucyl-(2s)-2,4-diaminobutanoyl-l-ornithyl-(2r)-2,4-diaminobutanoyl-(2s)-2,4-diaminobutanoyl-l-tryptophyl-(2s)-2,4-diaminobutanoyl-(2s)-2,4-diaminobutanoyl)

9. Unii-0d02gry87z

10. Murepavadin (usan/inn)

11. Murepavadin [usan:inn]

12. Murepavadin [usan]

13. Murepavadin [who-dd]

14. Chembl3946483

15. Gtpl10832

16. Ex-a4063

17. Rg7929

18. Akos037648482

19. Db14777

20. Rg-7929

21. Bs-14122

22. D10957

23. D80443

24. Q27236621

2.4 Create Date
2015-08-03
3 Chemical and Physical Properties
Molecular Weight 1553.8 g/mol
Molecular Formula C73H112N22O16
XLogP3-4.1
Hydrogen Bond Donor Count22
Hydrogen Bond Acceptor Count22
Rotatable Bond Count21
Exact Mass1552.86266557 g/mol
Monoisotopic Mass1552.86266557 g/mol
Topological Polar Surface Area618 Ų
Heavy Atom Count111
Formal Charge0
Complexity3200
Isotope Atom Count0
Defined Atom Stereocenter Count16
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Bacterial Agents

Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)


Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty